Door-to-balloon delays with percutaneous coronary intervention in ST-elevation myocardial infarction

American Heart Journal

Volumn 151, Issue 6 SUPPL., 2006, Pages

  Pinto, Duane S ^a   Southard, Matthew ^b   Ciaglo, Lauren ^b   Gibson, C Michael ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT;

BRAIN HEMORRHAGE; CLINICAL PRACTICE; CLINICAL PROTOCOL; CLINICAL TRIAL; FIBRINOLYSIS; HEART EJECTION FRACTION; HEART INFARCTION; HUMAN; META ANALYSIS; MORTALITY; NONHUMAN; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REPERFUSION; REVIEW; RISK ASSESSMENT; ST SEGMENT ELEVATION; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; EMERGENCY MEDICAL SERVICES; HUMANS; MYOCARDIAL INFARCTION; PATIENT TRANSFER; REGISTRIES; TIME FACTORS; UNITED STATES;

EID: 33744910600     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2006.04.010     Document Type: Review

References (41)

1. Braunwald E. The open-artery theory is alive and well-again. N Engl J Med 329 (1993) 1650-1652
2. The Gusto IIb Substudy Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators. N Engl J Med 336 (1997) 1621-1628
3. Grines C.L., Cox D.A., Stone G.W., et al. Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 341 (1999) 1949-1956
4. Bode C., Smalling R.W., Berg G., et al. Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction. The RAPID II Investigators. Circulation 94 (1996) 891-898
5. The Gusto Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. The GUSTO Angiographic Investigators. N Engl J Med 329 (1993) 1615-1622
6. Cannon C.P., Gibson C.M., McCabe C.H., et al. TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B Investigators. Circulation 98 (1998) 2805-2814
7. Keeley E.C., Boura J.A., and Grines C.L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361 (2003) 13-20
8. Weaver W.D., Simes R.J., Betriu A., et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA 278 (1997) 2093-2098
9. Nallamothu B.K., and Bates E.R. Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything?. Am J Cardiol 92 (2003) 824-826
10. Cannon C.P., Antman E.M., Walls R., et al. Time as an adjunctive agent to thrombolytic therapy. J Thromb Thrombolysis 1 (1994) 27-34
11. Rogers W.J., Dean L.S., Moore P.B., et al. Comparison of primary angioplasty versus thrombolytic therapy for acute myocardial infarction. Alabama Registry of Myocardial Ischemia Investigators. Am J Cardiol 74 (1994) 111-118
12. Every N.R., Parsons L.S., Hlatky M., et al. A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction. Myocardial Infarction Triage and Intervention Investigators. N Engl J Med 335 (1996) 1253-1260
13. Grines C.L., Browne K.F., Marco J., et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 328 (1993) 673-679
14. Zijlstra F., de Boer M.J., Hoorntje J.C., et al. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 328 (1993) 680-684
15. Reimer K.A., Lowe J.E., Rasmussen M.M., et al. The wavefront phenomenon of ischemic cell death: Part 1. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation 56 (1977) 786-794
16. Boersma E., Maas A.C., Deckers J.W., et al. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet 348 (1996) 771-775
17. Morrison L.J., Verbeek P.R., McDonald A.C., et al. Mortality and prehospital thrombolysis for acute myocardial infarction: a meta-analysis. JAMA 283 (2000) 2686-2692
18. Stone G.W. Primary angioplasty versus "earlier" thrombolysis-time for a wake-up call. Lancet 360 (2002) 814-816
19. Brodie B.R., Stuckey T.D., Wall T.C., et al. Importance of time to reperfusion for 30-day and late survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 32 (1998) 1312-1319
20. Brodie B.R., Stone G.W., Morice M.C., et al. Importance of time to reperfusion on outcomes with primary coronary angioplasty for acute myocardial infarction (results from the Stent Primary Angioplasty in Myocardial Infarction Trial). Am J Cardiol 88 (2001) 1085-1090
21. Antoniucci D., Valenti R., Migliorini A., et al. Relation of time to treatment and mortality in patients with acute myocardial infarction undergoing primary coronary angioplasty. Am J Cardiol 89 (2002) 1248-1252
22. Brodie B.R., Stuckey T.D., Muncy D.B., et al. Importance of time-to-reperfusion in patients with acute myocardial infarction with and without cardiogenic shock treated with primary percutaneous coronary intervention. Am Heart J 145 (2003) 708-715
23. O'Neill W.W., Grines C.L., and Dixon S. Does a 90-minute door to balloon time matter? Observations from 4 current reperfusion trials. J Am Coll Cardiol 45 (2005) 225A
24. Antman E.M., Anbe D.T., Armstrong P.W., et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 110 (2004) e82-e292
25. Cannon C.P., Gibson C.M., Lambrew C.T., et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA 283 (2000) 2941-2947
26. Joffe M.M., and Rosenbaum P.R. Invited commentary: propensity scores. Am J Epidemiol 150 (1999) 327-333
27. Rubin D.B. Estimating causal effects from large data sets using propensity scores. Ann Intern Med 127 (1997) 757-763
28. Smith Jr. S.C., Feldman T.E., Hirshfeld Jr. J.W., et al. ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol 47 (2006) e1-e121
29. Pinto D.S., Kirtane A.J., Barron H.V., et al. As door-to-balloon times exceed door-to-needle times at a given hospital, mortality in STEMI rises. Circulation 110 (2004) III-538 [2510]
30. Sheldon W.C. Trends in cardiac catheterization laboratories in the United States. Catheter Cardiovasc Interv 53 (2001) 40-45
31. Andersen H.R., Nielsen T.T., Rasmussen K., et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 349 (2003) 733-742
32. Aversano T., Aversano L.T., Passamani E., et al. Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery: a randomized controlled trial. JAMA 287 (2002) 1943-1951
33. Grines C.L., Westerhausen Jr. D.R., Grines L.L., et al. A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction: the Air Primary Angioplasty in Myocardial Infarction study. J Am Coll Cardiol 39 (2002) 1713-1719
34. Dalby M., Bouzamondo A., Lechat P., et al. Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infarction: a meta-analysis. Circulation 108 (2003) 1809-1814
35. Nallamothu B.K., Bates E.R., Herrin J., et al. Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysis. Circulation 111 (2005) 761-767
36. McNamara R.L., Herrin J., Bradley E.H., et al. Hospital improvement in time to reperfusion in patients with acute myocardial infarction, 1999 to 2002. J Am Coll Cardiol 47 (2006) 45-51
37. Bonnefoy E., Lapostolle F., Leizorovicz A., et al. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study. Lancet 360 (2002) 825-829
38. Caputo R.P., Ho K.K., Stoler R.C., et al. Effect of continuous quality improvement analysis on the delivery of primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. Am J Cardiol 79 (1997) 1159-1164
39. Kereiakes D.J., Gibler W.B., Martin L.H., et al. Relative importance of emergency medical system transport and the prehospital electrocardiogram on reducing hospital time delay to therapy for acute myocardial infarction: a preliminary report from the Cincinnati Heart Project. Am Heart J 123 (1992) 835-840
40. Krall S.P., Reese C.L., and Donahue L. Effect of continuous quality improvement methods on reducing triage to thrombolytic interval for acute myocardial infarction. Acad Emerg Med 2 (1995) 603-609
41. Henry T.D., Unger B.T., Sharkey S.W., et al. Design of a standardized system for transfer of patients with ST-elevation myocardial infarction for percutaneous coronary intervention. Am Heart J 150 (2005) 373-384